Director/PDMR Shareholding

RNS Number : 2799A

AstraZeneca PLC

28 March 2012

 



Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

The interest of David Brennan, a Director of the Company, in AstraZeneca PLC ordinary shares, has changed as detailed below. 

On 27 March 2012, Mr Brennan received shares from the vesting of a previously announced award made in March 2009 under the AstraZeneca Performance Share Plan (AZPSP) whereby, following the application of performance measures specified at the time of grant, he has now become beneficially entitled to 78% of the shares originally awarded. In accordance with the plan rules, any unvested part of the award has immediately and irrevocably lapsed. Sufficient shares were withheld to cover certain tax obligations arising on the vesting.

Name	Shares awarded	Shares vested	Shares withheld	Net shares received	Market price on vesting
David R Brennan	133,347	104,010	54,439	49,571	2854p

Mr Brennan has interests in both the ordinary shares and the American Depositary Shares (ADSs) of AstraZeneca PLC.  One ADS equals one ordinary share.

As a result of this transaction, Mr Brennan has an interest in 578,733 ordinary shares and 83,344 AstraZeneca ADSs, which together represent approximately 0.05% of the Company's issued ordinary capital.

A C N Kemp

Company Secretary

28 March 2012

 

END

 

 

RDSUWUORUSAOUAR